CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 11 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $61 | -84.4% | 89,270 | -72.6% | 0.00% | -100.0% |
Q2 2023 | $391 | -16.3% | 326,170 | -18.3% | 0.00% | 0.0% |
Q1 2023 | $467 | +44.6% | 399,270 | -2.4% | 0.00% | – |
Q4 2022 | $323 | -99.9% | 409,170 | +4.7% | 0.00% | -100.0% |
Q3 2022 | $473,000 | +35.1% | 390,770 | +2.7% | 0.00% | – |
Q2 2022 | $350,000 | +400.0% | 380,470 | +868.1% | 0.00% | – |
Q1 2022 | $70,000 | -96.1% | 39,300 | -95.6% | 0.00% | -100.0% |
Q3 2021 | $1,804,000 | -72.7% | 888,501 | -53.2% | 0.00% | -75.0% |
Q2 2021 | $6,606,000 | +275.1% | 1,898,351 | +91.9% | 0.01% | +300.0% |
Q1 2021 | $1,761,000 | +7904.5% | 989,096 | +4548.7% | 0.00% | – |
Q4 2020 | $22,000 | -60.0% | 21,277 | -76.9% | 0.00% | – |
Q1 2020 | $55,000 | +10.0% | 92,300 | +79.8% | 0.00% | – |
Q2 2019 | $50,000 | -51.0% | 51,333 | -28.2% | 0.00% | – |
Q1 2019 | $102,000 | +29.1% | 71,533 | -6.0% | 0.00% | – |
Q4 2018 | $79,000 | -21.0% | 76,133 | +30.5% | 0.00% | – |
Q3 2018 | $100,000 | – | 58,333 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
Virtu Financial LLC | 39,005 | $31 | 0.00% |
Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
Csenge Advisory Group | 15,000 | $11,850 | 0.00% |
Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
Syverson Strege & Co | 2,145 | $1,695 | 0.00% |